Literature DB >> 18787902

Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.

Richard A Smith1, K Dajani, S Dodd, P Whelan, M Raraty, R Sutton, F Campbell, J P Neoptolemos, P Ghaneh.   

Abstract

INTRODUCTION: Despite the widespread use of endoscopic biliary stenting in patients presenting with potentially resectable pancreatic cancer, there is no general consensus regarding whether this represents a superior management approach over expeditious surgical intervention. The objective of this study was to investigate the influence of preoperative biliary stenting and resolution of jaundice on subsequent postoperative survival following resection for pancreatic cancer.
METHODS: 155 patients undergoing partial pancreatoduodenectomy for pancreatic ductal adenocarcinoma between January 1997 and August 2007 were identified from a prospectively maintained database.
RESULTS: There was no survival difference when comparing patients undergoing preoperative biliary drainage (n = 130) with those who did not (n = 25) (log rank, P = 0.981). When analysing individual prognostic factors as continuous variables in univariate Cox analysis, lower albumin levels (P = 0.016), elevated alkaline phosphatase levels (P = 0.011) and elevated CRP levels (P = 0.021) were associated with poorer overall survival. Multivariable Cox regression demonstrated that both albumin (P = 0.008) and CRP (P = 0.038) remained significant independent predictors of overall survival alongside lymph node ratio (P = 0.018). Although preoperative bilirubin levels were not associated with overall survival when analysed as a continuous variable (Cox, P = 0.786), the presence of jaundice (i.e., bilirubin >35 micromol/l) at the time of surgery was a significant adverse predictor of early survival in patients undergoing preoperative biliary drainage (Breslow-Gehan-Wilcoxon, P = 0.013) and remained a significant predictor of early survival when included in a further Cox analysis with censoring of cases who survived beyond 6 months (Cox, P = 0.017).
CONCLUSION: These results suggest that the presence of jaundice at the time of resection has an adverse impact on early, but not overall, postoperative survival in pancreatic cancer patients undergoing preoperative biliary drainage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787902     DOI: 10.1245/s10434-008-0148-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  28 in total

1.  Surgical oncology: PBD-better stents in specialized centers are needed.

Authors:  John P Neoptolemos; Christopher M Halloran
Journal:  Nat Rev Clin Oncol       Date:  2010-05       Impact factor: 66.675

2.  PBD treatment of cancer of the head of the pancreas.

Authors:  Niels A van der Gaag; Dirk J Gouma
Journal:  Nat Rev Clin Oncol       Date:  2010-11       Impact factor: 66.675

3.  Unresectable pancreatic adenocarcinoma: do we know who survives?

Authors:  Mohammad H Jamal; Suhail A Doi; Eve Simoneau; Jad Abou Khalil; Mazen Hassanain; Prosanto Chaudhury; Jean Tchervenkov; Peter Metrakos; Jeffrey S Barkun
Journal:  HPB (Oxford)       Date:  2010-10       Impact factor: 3.647

Review 4.  Current status of preoperative drainage for distal biliary obstruction.

Authors:  Harutoshi Sugiyama; Toshio Tsuyuguchi; Yuji Sakai; Rintaro Mikata; Shin Yasui; Yuto Watanabe; Dai Sakamoto; Masato Nakamura; Reina Sasaki; Jun-Ichi Senoo; Yuko Kusakabe; Masahiro Hayashi; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-08-28

5.  Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: single centre experience.

Authors:  F Francesco di Mola; Francesca Tavano; R Rita Rago; Antonio De Bonis; M Rosa Valvano; Angelo Andriulli; Pierluigi di Sebastiano
Journal:  Langenbecks Arch Surg       Date:  2014-03-29       Impact factor: 3.445

Review 6.  Prognostic factors related with survival in patients with pancreatic adenocarcinoma.

Authors:  Ahmet Bilici
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

7.  The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.

Authors:  Christie Y Jeon; Donghui Li; Sean Cleary; Rachael Stolzenberg-Solomon; Cristina Bosetti; Carlo La Vecchia; Miquel Porta; Adetunji T Toriola; Rayjean J Hung; Robert C Kurtz; Sara H Olson
Journal:  Pancreas       Date:  2018-03       Impact factor: 3.327

8.  Predicting distant metastasis in patients with suspected pancreatic and periampullary tumors for selective use of staging laparoscopy.

Authors:  Annelie Slaar; Wietse J Eshuis; Niels A van der Gaag; C Yung Nio; Olivier R C Busch; Thomas M van Gulik; Johannes B Reitsma; Dirk J Gouma
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

9.  Percutaneous transhepatic insertion of self-expanding short metal stents for biliary obstruction before resection of pancreatic or duodenal malignancy proves to be safe and effective.

Authors:  Christopher D Briggs; Glen R B Irving; Andrew Cresswell; Robert Peck; Fred Lee; Mark Peterson; Iain C Cameron
Journal:  Surg Endosc       Date:  2009-07-16       Impact factor: 4.584

10.  Impact of biliary stenting on surgical outcome in patients undergoing pancreatectomy. A retrospective study in a single institution.

Authors:  Christos Agalianos; Konstantina Paraskeva; Nikolaos Gouvas; Demetrios Davides; Christos Dervenis
Journal:  Langenbecks Arch Surg       Date:  2015-11-14       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.